LONDON (Reuters) - GlaxoSmithKline and its partner Shionogi are progressing a new drug against HIV into final-stage clinical testing, ramping up competition in a class of AIDS drugs known as integrase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results